KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Margin (2016 - 2025)

Abbott Laboratories' FCF Margin history spans 17 years, with the latest figure at 22.92% for Q4 2025.

  • For Q4 2025, FCF Margin rose 334.0% year-over-year to 22.92%; the TTM value through Dec 2025 reached 16.68%, up 154.0%, while the annual FY2025 figure was 16.68%, 154.0% up from the prior year.
  • FCF Margin for Q4 2025 was 22.92% at Abbott Laboratories, up from 20.15% in the prior quarter.
  • Across five years, FCF Margin topped out at 22.92% in Q4 2025 and bottomed at 6.29% in Q1 2024.
  • The 5-year median for FCF Margin is 17.52% (2022), against an average of 16.39%.
  • The largest annual shift saw FCF Margin soared 1683bps in 2021 before it crashed -1107bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 21.39% in 2021, then dropped by -20bps to 17.01% in 2022, then surged by 31bps to 22.29% in 2023, then fell by -12bps to 19.57% in 2024, then rose by 17bps to 22.92% in 2025.
  • Per Business Quant, the three most recent readings for ABT's FCF Margin are 22.92% (Q4 2025), 20.15% (Q3 2025), and 13.87% (Q2 2025).